NCT03185390

Brief Summary

A periampullary lesion may be begin as duodenal adenoma, ampullary adenoma, gall stone pregnant ampulla, Stricture, or periampullary lipoma, or malignant as pancreatic ductal adenocarcinoma, distal CBD cholangiocarcinoma, ampullary carcinoma and periampullary duodenal adenocarcinoma, pancreatic carcinoma. The aim of the study is to detect incidence of different types of periampullary lesions detected by ERCP in Assuit University Hospital and the role of ERCP in early detection, diagnosis and management and diagnostic accuracy and sensitivity of biopsy and brush cytology taken by ERCP in a period of 1 years starting from June 2017 to June 2018.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 14, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

June 15, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

May 11, 2020

Status Verified

May 1, 2020

Enrollment Period

1 year

First QC Date

June 3, 2017

Last Update Submit

May 8, 2020

Conditions

Keywords

periampullary lesions

Outcome Measures

Primary Outcomes (1)

  • percentage of different types of periampullary massesand efficacy of ERCP guided biopsy calculating the number of cases correctly diagnosed by ERCP or guided biopsy

    one year

Secondary Outcomes (1)

  • number of cases addmited in Assiut University Hospital with differrent types of periampullary mass diagnosed correctly by the help of ERCP

    one year

Study Arms (1)

ERCP guided biopsy or brush cytology

OTHER

ERCP guided biopsy or brush cytology

Procedure: ERCP guided biopsy or brush cytology

Interventions

ERCP guided biopsy or brush cytology

ERCP guided biopsy or brush cytology

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All cases admitted in Assuit university hospital with periampullary lesions detected by ERCP within the period of the study.

You may not qualify if:

  • Cases diagnosed to have periampullary lesion and managed without ERCP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut Univesity Hospital

Asyut, Egypt

Location

Study Officials

  • morsy m morsy, professor

    prof

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All cases admitted in Assuit university hospital with periampullary lesions detected by ERCP with ERCP guided biopsy or brush cytology within the period of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle invvestigat

Study Record Dates

First Submitted

June 3, 2017

First Posted

June 14, 2017

Study Start

June 15, 2017

Primary Completion

June 15, 2018

Study Completion

May 1, 2019

Last Updated

May 11, 2020

Record last verified: 2020-05

Locations